CLINICAL_TRIALS
trial_result
· 2023-04-03
Clinical Trial Update: Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD [Phase 2]
Summary
A Phase 2 safety study evaluating Zimura in combination with anti-VEGF therapy for neovascular age-related macular degeneration was terminated, with results pos…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: IVERIC bio, Inc. | Conditions: Neovascular Age-Related Macular Degeneration | Phase 2 | Status: TERMINATED | Results posted: 2023-04-03